´â·Ç¼¨ÈÄTOP ·Ç¼¨ÈÄ ¥Á¥ã¥Ã¥È ¾ðÊ󸡺÷ Wiki ¼­Åµ ÏÀʸ ¥ê¥ó¥¯½¸ ¥¢¥ó¥±¡¼¥È Êݸ± ½ñÀÒ ÍÑÉÊ
£Í£ù¥í¥°¥¤¥ó

ÏÀʸʣ¼Ì

  Á´Ê¸¸¡º÷
¾ÜºÙ¸¡º÷  
  ÏÀʸʣ¼Ì » À©´âºÞÅù_ά¹æ » CPM ¥¢¥«¥¦¥ó¥È¾ðÊó  |  ¥«¡¼¥È¤ò¸«¤ë  |  ¥ì¥¸¤Ë¿Ê¤à   
´Êñ¸¡º÷
« À©´âºÞÅù_ά¹æ»
  254-S
  5-FU
  ADM
  ANA
  Ara-c
  ATRA
  CDGP
  CPA
CPM
  CPT-11
  DTIC
  DXR
  EPI
  G-CSF
  GEM
  IFM
  IFX
  L-OHP
  L-PAM
  NDP
  OK-432
  PEP
  SPAC
  STI571
  TAM
  TS-1 + ž°Ü
  TS-1¡Ü°ß´â
  TXL
  TXT
  UFT
  VCR
  VNR
  ZD1839
  ZOL
¥«¥Æ¥´¥ê¡¼¤Çõ¤¹ ÅÐÏ¿¹àÌܤÇõ¤¹
½ÐÈÇÃÄÂÎÊ̤Çõ¤¹½ÐÈÇÊ̤Çõ¤¹
°ìÍ÷¤Çõ¤¹ °ìÍ÷ɽ¼¨¤Çõ¤¹
¶È̳¡¦ÄêµÙ
ÀÖ¤ÎÆü¤ÏȯÁ÷¤ò¤ªµÙ¤ß¤µ¤»¤Æ¤¤¤¿¤À¤­¤Þ¤¹¡£
2008ǯ10·î
Æü ·î ²Ð ¿å ÌÚ ¶â ÅÚ
¡¡ ¡¡ ¡¡ 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31 ¡¡
¡¡
¥¤¥ó¥Õ¥©¥á¡¼¥·¥ç¥ó
¥Ë¥å¡¼¥¹
¤´ÍøÍÑÊýË¡
¸Ä¿Í¾ðÊóÊݸîÊý¿Ë
Áí³Ûɽ¼¨¤Ë¤Ä¤¤¤Æ
ÆÃÄ꾦¼è°úË¡¤Îɽ¼¨
¤è¤¯¤¢¤ë¼ÁÌä
¡¡¡¡¡ú²Á³Ê¤Ï¡©
¡¡¡¡¡ú»Ùʧ¤¤¤Ï¡©
¡¡¡¡¡úǼ´ü¤Ï¡©
¤ªÌ䤤¹ç¤ï¤»
¥µ¥Ý¡¼¥È·Ç¼¨ÈÄ

´Êñ¸¡º÷ CPA or CPM or ¥¨¥ó¥É¥­¥µ¥ó or ¥·¥¯¥í¥Û¥¹¥Õ¥¡¥ß¥É or Endoxan or Cyclophosphamide

¤³¤Î¥­¡¼¥ï¡¼¥É¤ÎRSS2.0
¡¡¹¹¤Ë¹Ê¹þ¤à: ¡¡
22²ó¡¡Âç²ñ 22²ó¡¡Âç²ñ

 ¿·Ãå½ç+   Ž×ŽÝŽ·ŽÝޏŽÞ 
 
¡ùºÆÈ¯Æý´â¤ËÂФ¹¤ë¹âÍÑÎÌ Toremifene¤È·Ð¸ý¹³´âºÞÊ»ÍÑÎÅË¡¤Î»ÈÍѷи³

  ¢£ºÆÈ¯Æý´â¾ÉÎã12Îã¡¡TOR.·Ð¸ý¹³´âºÞ..Ê»ÍÑÅêÍ¿¡¡PR °Ê¾å.ÁÕ¸ú.5Î㡡̵Áý°­´ü´Ö.5.8.·î¡¡Í­³²»ö¾Ý¡¡¹âÍÑÎÌTOR»ÈÍÑ.²½³ØÎÅË¡.Ê»ÍÑÌô...

  ¢£*¤ª¤ª¤â¤Èɱ¡...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° ºÆÈ¯Æý´â¤ËÂФ¹¤ë¹âÍÑÎÌ Toremifene¤È·Ð¸ý¹³´âºÞÊ»ÍÑÎÅË¡¤Î»ÈÍѷи³ ¤ò¿½¹þ¤à 
 
¡ùCD20ÍÛÀ­BºÙ˦À­Èó¥Û¥¸¥­¥ó¥ê¥ó¥Ñ¼ð¤ËÂФ¹¤ëDose-Dense, Dose-Intense²½³ØÎÅË¡¤ª¤è¤ÓRituximab²½³ØÎÅˡʻÍѤˤè¤ë¼£ÎÅÀ®ÀÓ

  ¢£ÂоÝ.CD 20ÍÛÀ­B ºÙ˦À­NHL36Îã¡¡¼£ÎÅË¡¡¡Î×¾²·Ð²á.¥â¥Ë¥¿¥ê¥ó¥°¡¡Restaging¡¡¸ú²ÌȽÄê´ð½à¡¡Dose intensity¡¡ÉûºîÍÑ¡¡Åý·×¡¡¼£ÎÅÀ®ÀÓ...

  ¢£*1ÀçÂæ·ì±Õ¼À´µ¥»¥ó¥¿¡¼, *2µÜ¾ë³Ø±¡½÷»ÒÂç³Ø¡¦¿©ÉʱÉÍܳØ...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ù

º£¤¹¤° CD20ÍÛÀ­BºÙ˦À­Èó¥Û¥¸¥­¥ó¥ê¥ó¥Ñ¼ð¤ËÂФ¹¤ëDose-Dense, Dose-Intense²½³ØÎÅË¡¤ª¤è¤ÓRituximab²½³ØÎÅˡʻÍѤˤè¤ë¼£ÎÅÀ®ÀÓ ¤ò¿½¹þ¤à 
 
¡ùTaxane(TX)ÂÑÀ­¤ÎºÆÈ¯¡¦Å¾°ÜÆý´â¤ËÂФ¹¤ë¼£Îť쥸¥á¥ó¤Î¸¡Æ¤

  ¢£2001ǯ1·î..2006ǯ5·î¡¡292ÎãÃæ246Îã.taxane(TX:docetaxel ... paclitaxel).ÅêÍ¿¡¡TX ÁÕ¸úÎã.̵¸úÎã.Èæ...±äÌ¿·¹¸þ...

  ¢£1Èæ±Ãɱ¡¡¦³°²Ê, *2ÆýÁ£¥¯¥ê¥Ë¥Ã¥¯»ù¶Ì³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° Taxane(TX)ÂÑÀ­¤ÎºÆÈ¯¡¦Å¾°ÜÆý´â¤ËÂФ¹¤ë¼£Îť쥸¥á¥ó¤Î¸¡Æ¤ ¤ò¿½¹þ¤à 
 
¡ùÆý´â½Ñ¸åÊä½õ²½³ØÎÅË¡¤Ë¤ª¤±¤ë Docetaxel+Cyclophosphamide(TC)ÎÅË¡¤Î°ÂÁ´À­

  ¢£Âоݡ¦ÊýË¡¡¡À®ÀÓ¡¡¹Í»¡¡¡Æý´â½Ñ¸åÊä½õÎÅË¡....TC ÎÅË¡.¥³¡¼¥¹¿ô.°ã....¸ú²Ì.°ã..Èæ³Ó¡¡TC ÎÅË¡.Æý´â½Ñ¸åÊä½õ²½³ØÎÅË¡...°ÂÁ´.¼Â¹Ô..ÆÀ....

  ¢£°¦É²Æý´âTCÎÅË¡¸¦µæ²ñ, *1Âçʬ¸©Î©É±¡¡¦³°²Ê, *2°¦É²...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° Æý´â½Ñ¸åÊä½õ²½³ØÎÅË¡¤Ë¤ª¤±¤ë Docetaxel+Cyclophosphamide(TC)ÎÅË¡¤Î°ÂÁ´À­ ¤ò¿½¹þ¤à 
 
¡ù»Ø¾õÖÈÆþºÙ˦Æù¼ð/¼ðáç¤Î1Îã

  ¢£¶Ë.......»Ø¾õÖÈÆþºÙ˦Æù¼ð/¼ðáç¾ÉÎã.Êó¹ð¡¡¾ÉÎã.52ºÐ,ÃËÀ­¡¡±¦æþãÝ.¥ê¥ó¥ÑÀáÀ¸¸¡.»Ü¹Ô¡¡Ãæ¡ÁÂç·¿ºÙ˦..Ì¡À­ÁýÀ¸.ǧ..¡¡cyclophosphamide/doxorub...

  ¢£*1ΰµåÂç³Ø°å³ØÉô¡¦ÆâʬÈçÂå¼ÕÆâ²Ê³Ø(ÂèÆóÆâ²Ê), *2¥Ï¡¼...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° »Ø¾õÖÈÆþºÙ˦Æù¼ð/¼ðáç¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ù¥æ¡¼¥¤¥ó¥°Æù¼ð¡¡¡Ý¾®»ù¤¬¤ó

  ¢£Î×¾²Áü¡¡.....¼£Îų«È¯¡¡ ²½³ØÎÅË¡¡¡VACD¡¡ Êü¼ÍÀþÎÅË¡¡¡ ¡¡ESFT¼£ÎÅ.ºÇ¶á.¿ÊÊâ¡¡...

  ¢£¹ñΩ¤¬¤ó¥»¥ó¥¿¡¼Ãæ±ûɱ¡¡¦¾®»ù²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ¥æ¡¼¥¤¥ó¥°Æù¼ð¡¡¡Ý¾®»ù¤¬¤ó ¤ò¿½¹þ¤à 
 
¡ùCEF(Cyclophosphamide, Epirubicin,5-Fluorouracil)¤ÈDocetaxelÊ»ÍѤνÑÁ°²½³ØÎÅË¡¤Ë¤è¤Ã¤ÆPathological CR¤È¤Ê¤Ã¤¿±ê¾ÉÀ­Æý´â¤Î1¾ÉÎã

  ¢£48ºÐ,½÷À­¡¡À¸¸¡..¿»½áÀ­Æý´É´â¡¡Í½¸åÉÔÎÉ.±ê¾ÉÀ­Æý´â¡¡²½³ØÎÅË¡.¥ì¥¸¥á¥ó.....pCR .²Äǽ¡¡¼£Ìþ.´üÂÔ...

  ¢£*1ÆÃḚ̂åÎÅË¡¿ÍÇî°¦²ñ ÁêÎÉɱ¡¡¦ÆýÁ£²Ê, *2ÆÃḚ̂åÎÅË¡¿Í...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ù

º£¤¹¤° CEF(Cyclophosphamide, Epirubicin,5-Fluorouracil)¤ÈDocetaxelÊ»ÍѤνÑÁ°²½³ØÎÅË¡¤Ë¤è¤Ã¤ÆPathological CR¤È¤Ê¤Ã¤¿±ê¾ÉÀ­Æý´â¤Î1¾ÉÎã ¤ò¿½¹þ¤à 
 
¡ùTS-1/CDDP Ê»ÍѽÑÁ°²½³ØÎÅË¡¤Ë¤è¤êPathological CR ¤¬ÆÀ¤é¤ì¤¿StageIV¿Ê¹Ô°ß´â¤Î1Îã

  ¢£¾ÉÎã.72ºÐ,ÃËÀ­¡¡À¸¸¡.½¼¼ÂÀ­Äãʬ²½Á£´â.¿ÇÃÇ¡¡Ê¢¹Ð¶À¸¡ºº...staging ..cT3N2M0H0P0CY1, cStageIV.¿ÇÃÇ¡¡½ÑÁ°¼£ÎÅ...TS-1.CDDP.Ê»ÍÑ...

  ¢£*1Âçºå·Ù»¡É±¡¡¦³°²Ê, *2Âçºå·Ù»¡É±¡¡¦ÉÂÍý²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ù

º£¤¹¤° TS-1/CDDP Ê»ÍѽÑÁ°²½³ØÎÅË¡¤Ë¤è¤êPathological CR ¤¬ÆÀ¤é¤ì¤¿StageIV¿Ê¹Ô°ß´â¤Î1Îã ¤ò¿½¹þ¤à 
 
¡ùÈó¥Û¥¸¥­¥ó¥ê¥ó¥Ñ¼ðÆñ¼£Îã¤ËÂФ¹¤ë²½³ØÎÅË¡¤ÈÊü¼ÍÀþ¼£ÎÅ¤ÎÆ±»þÊ»ÍÑÎÅË¡

  ¢£¾ÉÎã1.65ºÐ,ÃËÀ­¡¡±¦ðôÉô¥ê¥ó¥ÑÀá½éȯ.DLBCL¡¡¾ÉÎã2.54ºÐ,ÃËÀ­¡¡Î¾Â¦ðôÉô...°öƬ.DLBCL¡¡..2¾ÉÎã.ÂÐ..²½³ØÎÅË¡.Êü¼ÍÀþ¼£ÎÅ.Ʊ»þÊ»ÍÑÎÅË¡¡¡É¸½à²½³ØÎÅË¡.Äñ¹³...

  ¢£*1»ÔΩÅ×ÇÈÁí¹çɱ¡¡¦Æâ²Ê, *2»ÔΩÅ×ÇÈÁí¹çɱ¡¡¦·ì±ÕÆâ²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° Èó¥Û¥¸¥­¥ó¥ê¥ó¥Ñ¼ðÆñ¼£Îã¤ËÂФ¹¤ë²½³ØÎÅË¡¤ÈÊü¼ÍÀþ¼£ÎÅ¤ÎÆ±»þÊ»ÍÑÎÅË¡ ¤ò¿½¹þ¤à 
 
¡ù͹âÎð¼Ô¤Î¿ºÞÂÑÀ­ºÆÈ¯Æý´â¤ËÄãÍÑÎÌCapecitabine¤¬ÁÕ¸ú¤·¤¿1Îã

  ¢£85ºÐ,½÷À­¡¡Â¿ºÞÂÑÀ­ºÆÈ¯Æý´â¡¡¼ðáç·Â.½Ì¾®Î¨50%¡¡CA 15-3.18.8U/ml ..¸º¾¯¡¡partial response.5.·î´Ö°Ý»ý...

  ¢£¿·³ã¸©¸üÀ¸ÇÀ¶ÈÁȹçÏ¢¹ç²ñÆÊÈø¶¿É±¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 *¡ú

º£¤¹¤° ͹âÎð¼Ô¤Î¿ºÞÂÑÀ­ºÆÈ¯Æý´â¤ËÄãÍÑÎÌCapecitabine¤¬ÁÕ¸ú¤·¤¿1Îã ¤ò¿½¹þ¤à 
 
°ß°­À­¥ê¥ó¥Ñ¼ð¤Î²½³ØÎÅË¡Ãæ¤Ë°ßÀü¹¦¤Ë¤è¤ëÊ¢Ëì±ê¤ò¤­¤¿¤·¤¿1 Îã

  ¢£CHOP¡Êcyclophosphamide¡¤doxorubicin,Vin-cristine¡¤prednisolone¡Ë...²½³ØÎÅË¡...°ß°­À­¥ê¥ó¥Ñ¼ð.¼£ÎÅÀ®ÀÓ.¸þ¾å........

  ¢£¼Ò²ñÊݸ±²¼´Ø¸üÀ¸Ä˱¡...  ¢£588±ß(ÀÇÈ´560±ß)  
 ¡ú¡ú¡ú¡ù

º£¤¹¤° °ß°­À­¥ê¥ó¥Ñ¼ð¤Î²½³ØÎÅË¡Ãæ¤Ë°ßÀü¹¦¤Ë¤è¤ëÊ¢Ëì±ê¤ò¤­¤¿¤·¤¿1 Îã ¤ò¿½¹þ¤à 
 
·ÐÉ¡»ý³ÍÛ°µµ¤Æ»°µË¡¤òÊ»ÍѤ·¶»ËìÌþÃå½Ñ¤¬ÁÕ¸ú¤·¤¿Æñ¼£À­´ÎÀ­¶»¿å¤Î2Îã

  ¢£´ÎÀ­¶»¿å¡¡nasal CPAP¡¡ ¶»ËìÌþÃå½Ñ Nasal CPAPÊ»ÍѶ»ËìÌþÃå½Ñ...

  ¢£1) Ê¡Å縩Ω°å²ÊÂç³Ø°å³ØÉôÂèÆóÆâ²Ê...  ¢£441±ß(ÀÇÈ´420±ß)  
 ¡ú¡ú¡ú¡ú

º£¤¹¤° ·ÐÉ¡»ý³ÍÛ°µµ¤Æ»°µË¡¤òÊ»ÍѤ·¶»ËìÌþÃå½Ñ¤¬ÁÕ¸ú¤·¤¿Æñ¼£À­´ÎÀ­¶»¿å¤Î2Îã ¤ò¿½¹þ¤à 
 
½ÑÁ°Êü¼ÍÀþ²½³ØÎÅË¡¤Ë¤è¤êCR(Ef.3)¤¬ÆÀ¤é¤ì´°Á´ÀÚ½ü²Äǽ¤Ç¤¢¤Ã¤¿Pancoast¼ðáç¤Î1Îã

  ¢£...

  ¢£*1ÆÈΩ¹ÔÀ¯Ë¡¿Í¹ñΩɱ¡µ¡¹½»³ÍÛɱ¡¡¦¸ÆµÛ´ï³°²Ê, *2ÆÈΩ...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ú¡ú

º£¤¹¤° ½ÑÁ°Êü¼ÍÀþ²½³ØÎÅË¡¤Ë¤è¤êCR(Ef.3)¤¬ÆÀ¤é¤ì´°Á´ÀÚ½ü²Äǽ¤Ç¤¢¤Ã¤¿Pancoast¼ðáç¤Î1Îã ¤ò¿½¹þ¤à 
 
¿Ê¹ÔºÆÈ¯Æý´â¤ËÂФ¹¤ëDocetaxel/CyclophosphamideÊ»ÍÑÎÅË¡¤Î°ÂÁ´À­¤Ë´Ø¤¹¤ë¸¡Æ¤

  ¢£...

  ¢£ÅìµþÅÔºÑÀ¸²ñÃæ±ûɱ¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ú¡ù

º£¤¹¤° ¿Ê¹ÔºÆÈ¯Æý´â¤ËÂФ¹¤ëDocetaxel/CyclophosphamideÊ»ÍÑÎÅË¡¤Î°ÂÁ´À­¤Ë´Ø¤¹¤ë¸¡Æ¤ ¤ò¿½¹þ¤à 
 
¥ê¥ó¥ÑÀáž°ÜÍÛÀ­Æý´â¤ËÂФ¹¤ë½Ñ¸åÊä½õÎÅË¡¤È¤·¤Æ¤ÎCyclophosphamide+Adriamycin+Fluorouracil(CAFÎÅË¡)¤ÈUracil-Tegafur(UFT)+Tamoxifen(UFT+TAMÎÅË¡)¤È¤ÎÈæ³Ó

  ¢£ÂоÝ.ÊýË¡¡¡ ·ë²Ì¡¡CAF·²¡¦UFT+TAM·²³Æ82¾ÉÎã¡¡ ¹Í»¡¡¡...

  ¢£*1ÂçºåÉÜΩÀ®¿ÍÉÂ¥»¥ó¥¿¡¼, *2Âçºå»ÔΩÂç³Ø, *3µþÅÔÉÜ...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ú¡ú¡ù

º£¤¹¤° ¥ê¥ó¥ÑÀáž°ÜÍÛÀ­Æý´â¤ËÂФ¹¤ë½Ñ¸åÊä½õÎÅË¡¤È¤·¤Æ¤ÎCyclophosphamide+Adriamycin+Fluorouracil(CAFÎÅË¡)¤ÈUracil-Tegafur(UFT)+Tamoxifen(UFT+TAMÎÅË¡)¤È¤ÎÈæ³Ó ¤ò¿½¹þ¤à 
 
¥ê¥ó¥ÑÀáž°ÜÍÛÀ­Æý´â¤ËÂФ¹¤ë½Ñ¸åÊä½õ²½³ØÎÅË¡¤È¤·¤Æ¤ÎDoxorubicin Plus Cyclophosphamide Followed by Weekly PaclitaxelÎÅË¡¤Î¸¡Æ¤

  ¢£ÂоÝ...ÊýË¡¡¡ ·ë²Ì¡¡47¾ÉÎ㎥ʿ¶Ñ52ºÐŽ¥ÊÄ·ÐÁ°19Î㡦Êķиå28Îã¡¡ ¹Í»¡¡¡...

  ¢£*1Ë̶彣»ÔΩ°åÎÅ¥»¥ó¥¿¡¼¡¦³°²Ê, *2ÆüËÜÀÖ½½»ú¼ÒĹºê¸¶Çú...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ú¡ú¡ù

º£¤¹¤° ¥ê¥ó¥ÑÀáž°ÜÍÛÀ­Æý´â¤ËÂФ¹¤ë½Ñ¸åÊä½õ²½³ØÎÅË¡¤È¤·¤Æ¤ÎDoxorubicin Plus Cyclophosphamide Followed by Weekly PaclitaxelÎÅË¡¤Î¸¡Æ¤ ¤ò¿½¹þ¤à 
 
À©ÅǺޤËÏ»·¯»ÒÅò¤ÎÊ»ÍѤˤè¤êÀ©ÅǺîÍѤ¬Ãø¸ú¤·¤¿¿Ê¹ÔÆý´â²½³ØÎÅË¡¤Î1Îã

  ¢£¾ÉÎã:45ºÐ½÷À­¡¡º¸ÆýÁ£¼ðáî.µ¤ÉÕ.¼õ¿Ç¡¡CR.ȽÄê¡¡ ¹Í»¡...

  ¢£*1¤È¤â¤Î¥¯¥ê¥Ë¥Ã¥¯, *2ÈØÅÄ»ÔΩÁí¹çɱ¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ú¡ú

º£¤¹¤° À©ÅǺޤËÏ»·¯»ÒÅò¤ÎÊ»ÍѤˤè¤êÀ©ÅǺîÍѤ¬Ãø¸ú¤·¤¿¿Ê¹ÔÆý´â²½³ØÎÅË¡¤Î1Îã ¤ò¿½¹þ¤à 
 
»ÒµÜÂδâ¤Î½Ñ¸åÊä½õ²½³ØÎÅË¡¤È¤·¤Æ¤ÎPaclitaxel+CarboplatinÊ»ÍÑÎÅË¡¤Î¼£ÎÅÀ®ÀÓ¡¾CAPÎÅË¡¤ÈÈæ³Ó¤·¤Æ

  ¢£ÂоÝ.ÊýË¡¡¡»ÒµÜÂδâ53¾ÉÎã¡¡ ·ë²Ì¡¡ ¹Í»¡...

  ¢£ÆàÎɸ©Î©°å²ÊÂç³Ø¡¦»º²ÊÉØ¿Í²Ê³Ø¶µ¼¼...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ú¡ú

º£¤¹¤° »ÒµÜÂδâ¤Î½Ñ¸åÊä½õ²½³ØÎÅË¡¤È¤·¤Æ¤ÎPaclitaxel+CarboplatinÊ»ÍÑÎÅË¡¤Î¼£ÎÅÀ®ÀÓ¡¾CAPÎÅË¡¤ÈÈæ³Ó¤·¤Æ ¤ò¿½¹þ¤à 
 
°ß´âǾž°Ü¤ËPaclitaxelÅêÍ¿¤¬Í­ÍѤǤ¢¤Ã¤¿1Îã

  ¢£¾ÉÎã¡§76ºÐÃËÀ­¡¡ÓÒµ¤¡¦âÁÚô..¼õ¿Ç¡¡¡¡ ¹Í»¡¡¡...

  ¢£µªÍβñ²¬ËÜɱ¡¡¦³°²Ê...  ¢£630±ß(ÀÇÈ´600±ß)  
 ¡ú¡ú¡ú

º£¤¹¤° °ß´âǾž°Ü¤ËPaclitaxelÅêÍ¿¤¬Í­ÍѤǤ¢¤Ã¤¿1Îã ¤ò¿½¹þ¤à 
 
Trastuzumab¤Èpaclitaxel¤Î½ÑÁ°²½³ØÎÅË¡¤Çpathological CR¤¬ÆÀ¤é¤ì¤¿anthracyclineÄñ¹³À­¶É½ê¿Ê¹ÔÆý´â¤Î1¾ÉÎã

  ¢£¾ÉÎã¡¡58ºÐ½÷À­¡¡...

  ¢£*1·²ÇÏÂç³ØÂç³Ø±¡°å³Ø·Ï¸¦µæ²Ê¡¦Â¡´ïÉÂÂÖ³°²Ê³Ø, *2·²ÇÏÂç...  ¢£588±ß(ÀÇÈ´560±ß)  
 ¡ú¡ú¡ú

º£¤¹¤° Trastuzumab¤Èpaclitaxel¤Î½ÑÁ°²½³ØÎÅË¡¤Çpathological CR¤¬ÆÀ¤é¤ì¤¿anthracyclineÄñ¹³À­¶É½ê¿Ê¹ÔÆý´â¤Î1¾ÉÎã ¤ò¿½¹þ¤à 
 1 - 20 ÈÖÌܤòɽ¼¨ (79 ¤¢¤ëÏÀʸ¤Î¤¦¤Á)   ¥Ú¡¼¥¸:  1  2  3  4  [¼¡¥Ú¡¼¥¸ >>]  
Á°¤ËÌá¤ë
°ÊÁ°¤´ÍøÍѤµ¤ì¤¿Êý
E-Mail ¥¢¥É¥ì¥¹:
¥Ñ¥¹¥ï¡¼¥É:
¥Ñ¥¹¥ï¡¼¥Éʶ¼º
Åê¹Æ¥µ¡¼¥Á
 
¤Á¤ç¤Ã¤È½Å¤¤¤Ç¤¹
´ØÏ¢¤Î¤¢¤ë½ñÀÒ
¥ì¥Ó¥å¡¼

À¸Â¸¼Ô¤ÎÅý·×Ū¤Ê²òÀϤǤ¢¤ê¡¢À¸Â¸¼Ô¤Ë´Ø¤·¤Æ¤Î¿¼¤¤Ê¬ÀϤǤϤ¢¤ê ..
5ÅÀÃæ¤Î 1ÅÀ!
       TOP ¥¢¥«¥¦¥ó¥È¾ðÊó  |  ¥«¡¼¥È¤ò¸«¤ë  |  ¥ì¥¸¤Ë¿Ê¤à